Clinical Trial Services

Feb 02, 2016
By Pharmaceutical Technology Editors
Catalent plans a $4.6 million investment to expand secondary packaging and storage in Asia.
Feb 01, 2016
Pharmaceutical Technology
Only half of new drugs make it past Phase III. Adopting best practices and collaborating more closely with contract research organizations can help ensure success.
Feb 01, 2016
Pharmaceutical Technology
Mergers and acquisitions have changed the shape of the contract services market as big players seek to build full-service capabilities.
Feb 01, 2016
Pharmaceutical Technology
Steven Denham, director of biostatistics at MPI Research, discusses the impact the Standard for Exchange of Nonclinical Data may have on the pharmaceutical industry.
Sep 08, 2015
By Pharmaceutical Technology Editors
The partners will collaborate on a project to capture and integrate clinical trial data metrics on investigational cancer medications.
May 26, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
EMA confirms its recommendation to suspend medicines approved based on GVK Biosciences studies.
Apr 15, 2015
By Pharmaceutical Technology Editors
Pfizer announces that its Phase III trial for Ibrance met its primary endpoint and was ended early due to efficacy based on an assessment by an independent Data Monitoring Committee.
Jan 23, 2015
By Pharmaceutical Technology Editors
EMA Recommends Suspension of 700 Drugs Tested at GVK Site GVK Biosciences argues that EMA’s recommended suspension of 700 drugs is disproportional to reported infractions.
Aug 01, 2014
Pharmaceutical Technology
Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.
Feb 01, 2014
Pharmaceutical Technology
The relatively low success rates for bio/pharmaceutical compounds in clinical development have prompted many organizations to explore ways of reducing risk in clinical development.
native1_300x100
lorem ipsum